Bionano Genomics
BNGO
$0.96
Share price
-4.01%
Change (1 day)
31.03%
Change (1 year)
Operating Margin for Bionano Genomics (BNGO)
Operating Margin as of May 2024 (TTM): -466.00%
According to Bionano Genomics 's latest financial reports and stock price the company's current Operating Margin is -466.00%. At the end of 2021 the company had an Operating Margin of -434.64%.
Operating Margin history for Bionano Genomics from 2017 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -434.64% | -10.03% |
| 2020 | -483.09% | 64.24% |
| 2019 | -294.13% | 91% |
| 2018 | -154.00% | -37.3% |
| 2017 | -245.63% | -11.42% |
| 2016 | -277.29% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 PerkinElmer
PKI | 14.13% | -103.03% | 🇺🇸 USA |
 Quanterix QTRX | -68.36% | -85.33% | 🇺🇸 USA |
 Precipio PRPO | -96.24% | -79.35% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.